BIO Asia - Taiwan 2023 | Taiwan Bio Industry Organization | 26 July 2023 | Nangang Exhibition Center, No. 1, Jingmao 2nd Rd, Nangang District, Taipei City, Taiwan 115

The event aims to build on the success of recent years’ gatherings to bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia, and explore business opportunities and to engage with Taiwan’s emerging biotech sector. The five-day gathering will feature a three-day conference with internationally-renowned speakers, company presentations from Asia and around the world, BIO One-on-One Partnering™ meetings, symposia and workshops, and an international exhibition. Each element of the gathering will also be accessible online in either live or on-demand formats; ideal for repeat viewings or for delegates unable to attend in person.

The conference will focus on three major topic areas:
• Innovation – covering precision health, AI and digital health, and others.
• Market & Supply – including biosimilars, vaccines, contract development & manufacturing, APIs and generics, among others.
• Investment – covering early-stage financing, cross border investment, capital markets, and more.

This event will showcase growing digital advantage in the biomed sector and spotlight biotech, pharmaceutical, medical devices, precision medicine advances, as well as AI applications, ICT and IoT technologies, and new healthcare/medical investment opportunities.

2023 Speakers

Johnsee Lee
Chairman of BIO Asia–Taiwan

John A. Murphy, III
Chief Policy Officer Deputy Counsel, Healthcare, Biotechnology Innovation Organization (BIO)

Pieter Cullis
Professor, University of British Columbia, 2022 Tang Prize Laureate

Katalin Karikó
Professor of University of Pennsylvania, Senior Vice President of BioNTech RNA Pharmaceuticals, 2022 Tang Prize Laureate

Reenita Das
Partner, Senior Vice President in healthcare and life sciences global, Frost & Sullivan

Drew Weissman
Professor, University of Pennsylvania, 2022 Tang Prize Laureate

Sam Wilson
SVP and Head of APAC, Deployment Solutions, Syneos Health

Aurelio Arias
Director, Global Thought Leadership, IQVIA

Basha Kodidela
Senior Manager – Technical Sales APAC, BIOVIA

Jens Neumann
Partner, Pharmaceutical and Life Sciences Operations Strategy Leader in Europe, PwC Strategy& (Germany) GmbH

Chung-Hsiun Wu
Chairman, Taiwan Bio Industry Organization

Hidehito Katsuma
President, IRPMA; President, Eli Lilly Taiwan

Pei-Chieh Fong
VP Medical International, AstraZeneca

Francois Barbe
Head of Digital Healthcare, Sanofi Hong Kong and Taiwan

Joseph Chou
Chairman, CEO, PwC Taiwan

PANELIST:

Claudio Longo
Company President, AstraZeneca Taiwan Limited

Chih-Hsin Yang
Superintendent, National Taiwan University Cancer Center

Panchyr Yang
Academician of Academia Sinica

Tzu-jen Hung
Chairman, Taiwan College of Healthcare Executive

Luk Vandenberghe
Associate Professor, Harvard Medical School & an Associate Member of the Broad Institute of Harvard & MIT. Founder, AKOUOS

Feng Ren
Co-CEO, CSO, Insilico Medicine

Gur Roshwalb
Partner, aMoon

Melika Davis
SVP & Global Head, Clinical Operations, BeiGene

Sam Thong
Managing Director, Goldman Sachs

Makiko Iwai
Head of Healthcare IB, Citi Group

David Chen
Vice Director, Business Development Greater China, Nasdaq

Michael Brinkman
Managing Director, Joint US Head of Biopharmaceuticals Investment Banking, Jefferies, LLC

MODERATOR:

John Tsai
Former President Global Drug Development & CMO of Novartis; Blueprint Medicines Board member

Peter Kurz
Chief Strategy Officer, QIC International

2023 Speakers

DIAMOND:
• PwC
• Diamond Biofund
• Syneos Health
• Industrial Technology Research Institute
• Taiwania
• Iqvia
• Baker McKenzie

GOLD:
• DCI Partners
• IRPMA
• Sanofi
• Develpment Center for Biotechnology
• Academia Sinica
• National Biotechnology Research Park
• Biotrec
• National Health Research Institutes
• CDIB Capital Group
• Taipei Medical University
• Formosa Laboratories, Inc

SILVER:
• Pmia Taiwan
• GenScript
• Biovia
• Cytiva

GENERAL SPONSOR:
• TWSE
• National Development Fund
• Taipei Exchange
• Firdi
• BeiGene
• Deloitte
• Taimed Biologics
• Eir Genix
• Bora Biologics
• Finnegan
• Sunny Pharmtech
• Mycenax
• Sinphar Group
• Syn-tech
• Senhwa Biosciences
• Tanvex
• Handa Pharmaceutical, Inc
• Boehringer Ingelheim

ASSOCIATION PARTNER:
• Japan Bioindustry Association
• Bio Korea
• Tcels
• Biohk2023
• Europe-Taiwan Biotech Association
• China Bio
• Pmda
• Taipei Biotech Association
• Taiwan Clinical Research Association
• Irpma
• Semi
• Trpma
• Pmia Taiwan
• Tfmdca
• Tmbia
• Tgpa
• Tsitc
• Teha
• Taidha
• Biotech Industrial Academy